BBIO
Bridgebio Pharma Inc Earnings
$71.27
Earnings Summary
Revenue | $154.18Mn |
Net Profits | $-197.24Mn |
Net Profit Margins | -127.93% |
Bridgebio Pharma Inc’s revenue jumped 2521.22% since last year same period to $154.18Mn in the Q4 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated 27.74% jump in its revenue since last 3-months.
Bridgebio Pharma Inc’s net profit jumped 25.58% since last year same period to $-197.24Mn in the Q4 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -7.93% fall in its net profits since last 3-months.
Bridgebio Pharma Inc’s net profit margin jumped 97.16% since last year same period to -127.93% in the Q4 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated 15.51% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.64 |
EPS Estimate Current Year | -0.64 |
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.64 - a 10.18% jump from last quarter’s estimates.
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.64.
Key Ratios
Earning Per Share (EPS) | 0 |
Bridgebio Pharma Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Bridgebio Pharma Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-30 | -0.64 | 0 | 100% |
